テキサスにおける子宮頸がんの臨床試験
テキサス内の拠点で、子宮頸がんに関する45件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- University of Texas MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics (START), San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
- MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT07189871Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Total Women's Care of the Heights, Houston
- Medical Colleagues of Texas, LLP, Katy
被験者募集中観察研究
18歳以上 · 女性 · 2026/09/29更新 · NCT05051722Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Texas Oncology - DFW, Arlington
- Texas Oncology - Central South, Austin
- Texas Oncology - Central South, Austin
- 他13件
被験者募集中第4相
18歳以上 · 女性 · 2026/09/25更新 · NCT06952660A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Texas Oncology - DFW ( Site 8005), Fort Worth
- Houston Methodist Hospital-Obstetrics and Gynecology ( Site 6010), Houston
- Texas Oncology-The Woodlands ( Site 8000), The Woodlands
- 他1件
被験者募集中第3相
18歳以上 · 女性 · 2026/09/25更新 · NCT07216703Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Baylor, Scott and White Research Institute, Dallas
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06047379Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Oncology Consultants, P.A., Houston
- University of Texas M.D. Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- M D Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/18更新 · NCT04038619A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- MD Anderson Cancer Center, Houston
- START Center for Cancer Research, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07109726Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)
- M D Anderson Cancer Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT05475171Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
- M D Anderson Cancer Center, Houston
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/14更新 · NCT04723095Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Start - Dfw, Fort Worth
- Oncology Consultants, Houston
- START - San Antonio, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06293898A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- The University of Texas - MD Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- NEXT Austin, Austin
- NEXT San Antonio, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT07227168A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Dallas
- Normunity Investigational Site, Houston
- Normunity Investigational Site, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07182149Evaluation of a Novel Optical Microscope With a Deep Depth of Field (DeepDOF) to Provide Histologic-quality Images on Cervical Biopsies and Loop Electrosurgical Excision Procedure (LEEP) Specimens at the Point-of-care
- The University of Texas M. D. Anderson Cancer Center, Houston
被験者募集中
25歳〜49歳 · 女性 · 2026/08/18更新 · NCT06850402A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Houston Methodist Hospital, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04895709A Study of MGC026 in Participants With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Texas, MD Anderson Cancer Center, Houston
- UT Health Mays Cancer Center, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626Rice Technologies for Cervical Cancer Screening and Diagnosis
- M D Anderson Cancer Center, Houston
被験者募集中
25歳〜49歳 · 女性 · 2026/08/10更新 · NCT05372484A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Clinical Trial Site, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/06更新 · NCT07749586IDOV-Immune for Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
- South Texas Accelerated Research Therapeutics, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06910657A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Texas Oncology - West Texas, Amarillo
- Texas Oncology, P.A., Dallas
- Texas Oncology Gulf Coast, Pearland
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06330064Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
- UT MD Anderson Cancer Center, Houston
被験者募集中健康なボランティア歓迎
25歳以上 · 女性 · 2026/07/31更新 · NCT07281430A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- Texas Oncology-Austin, Austin
- Texas Oncology- GYN ONC DFWW, Bedford
- Texas Oncology-DFWW, Bedford
- 他9件
被験者募集中
18歳以上 · 女性 · 2026/07/30更新 · NCT04831580Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
- NEXT San Antonio, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/22更新 · NCT07524322First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
- University of Texas MD Anderson Cancer Center, Houston
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/07更新 · NCT05768139A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Oncology Consultants, PA, Houston
- Oncology Consultants, PA., Houston
- The University of Texas M.D. Anderson Cancer Center, Houston
- 他5件
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/06更新 · NCT04389632Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- START, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/23更新 · NCT06993844Unidos Contra el VPH
- Project Vida Health Center, El Paso
被験者募集中健康なボランティア歓迎
30歳〜65歳 · 女性 · 2026/06/10更新 · NCT06825689Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
- UT Southwestern Medical Center, Dallas
被験者募集中第2相
18歳以上 · 女性 · 2026/05/06更新 · NCT06266338Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
- NEXT Oncology, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/06更新 · NCT06239194A Study of VET3-TGI in Patients With Solid Tumors
- Mary Crowley Cancer Research, Dallas
- University of Texas MD Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/07更新 · NCT06444815Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
- M D Anderson Cancer Center, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/03/11更新 · NCT03968406cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Elligo Health Research, Inc., Austin
被験者募集中観察研究健康なボランティア歓迎
40歳以上 · 全性別 · 2026/01/20更新 · NCT05366881A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Austin
- Dren Investigational Site, Dallas
- Dren Investigational Site, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/01/07更新 · NCT06999187A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/12/11更新 · NCT06943521ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。